Intuitive Surgical stock heads into the open after a 2.2 percent gain

At the close on September 16, 2026, Intuitive Surgical stock finished at USD 381.56 on the Nasdaq, up 2.19 percent; the move came as Wall Street digested a Federal Reserve rate hike and mixed broader index performance.

Intuitive Surgical stock closed at USD 381.56 on the Nasdaq on September 16, 2026, representing a 2.19% gain versus the prior session and bucking the broader market’s mixed tone.

September 16, 2026 in numbers

Intuitive Surgical Inc. (ISIN US46120E6023, Nasdaq: ISRG) ended the September 16, 2026 session at USD 381.56 on its primary Nasdaq listing, advancing 2.19% compared with the previous close as reported in end-of-day US market coverage from MarketWatch data and sector wraps such as the overview cited by Sharecast.

On the same day, major US indices reacted negatively to the Federal Reserve’s latest interest rate increase, with the Dow Jones Industrial Average losing 1.21%, the S&P 500 falling 0.44% and the Nasdaq Composite slipping 0.01% at the September 16, 2026 close, according to coverage from The Straits Times. This left Intuitive Surgical outperforming the Nasdaq Composite in that session by a little over 2 percentage points. While detailed intraday figures such as day high, day low and volume were not highlighted in the available week-filtered data, the confirmed close and percentage move indicate the shares traded firmly within their recent range and above the level implied by sector commentary that referenced a present share price of around USD 371.88 earlier in the week, as discussed by Simply Wall St.

Today’s factors for Intuitive Surgical

Today, September 17, 2026, investors in Intuitive Surgical focus on the broader macro backdrop following the Federal Reserve’s rate decision, with US economic calendars showing a series of data releases and events scheduled that could influence risk appetite in growth and healthcare names, according to the overview provided by Marketkin. In parallel, recent commentary on the stock’s valuation and regulatory momentum, including discussion of its CE Mark approval and associated growth expectations in international markets highlighted by Simply Wall St, continues to frame sentiment ahead of the opening bell, even as the next specific quarterly reporting date for Intuitive Surgical is not singled out in the most recent week-filtered earnings references. With Wall Street’s last session having closed lower on index level despite Intuitive Surgical’s individual gain, today’s trade opens against a backdrop of caution on interest rates combined with ongoing attention to healthcare and medical-technology names that showed relative strength in the previous session.